Ohio Medicaid Drug Lives by Payer and PBM, as of March 2021
April
12
Ohio’s 2.4 million Medicaid drug lives are currently managed by five PBMs, which contract with both the state and its managed care plans. Gainwell Technologies will take over as the state’s single PBM in 2022, the beginning of a 7.5-year contract. Ohio is also rebidding its Medicaid managed care contracts for 2022, but it’s unclear when awards will be unveiled.
SOURCE: MMIT Analytics as of 3/30/21.
Related Posts
September
21
McClellan: IRA Price Negotiations May Have Broader Impact Beyond Drugs on List
Read More
September
21
FDA Approves First Multiple Sclerosis Biosimilar, Sandoz’s Tyruko
Read More
September
21
Now That Humira Biosimilars Have Launched, What Are Lessons Learned for Stelara Biosimilars?
Read More
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile